481 related articles for article (PubMed ID: 24133963)
1. [Sphingosine kinase 1 and tumor].
Zhang CX; He HW; Shao RG
Yao Xue Xue Bao; 2013 Jul; 48(7):971-8. PubMed ID: 24133963
[TBL] [Abstract][Full Text] [Related]
2. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
Maceyka M; Payne SG; Milstien S; Spiegel S
Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
Hait NC; Oskeritzian CA; Paugh SW; Milstien S; Spiegel S
Biochim Biophys Acta; 2006 Dec; 1758(12):2016-26. PubMed ID: 16996023
[TBL] [Abstract][Full Text] [Related]
6. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
[TBL] [Abstract][Full Text] [Related]
7. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
Van Brocklyn JR; Williams JB
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
[TBL] [Abstract][Full Text] [Related]
8. Targeting SphK1 as a new strategy against cancer.
Shida D; Takabe K; Kapitonov D; Milstien S; Spiegel S
Curr Drug Targets; 2008 Aug; 9(8):662-73. PubMed ID: 18691013
[TBL] [Abstract][Full Text] [Related]
9. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
10. Drugging sphingosine kinases.
Santos WL; Lynch KR
ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
[TBL] [Abstract][Full Text] [Related]
11. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
13. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
14. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
Hait NC; Maiti A
Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Sphk1/S1P and microRNAs in human cancers.
Khoei SG; Sadeghi H; Samadi P; Najafi R; Saidijam M
Biotechnol Appl Biochem; 2021 Apr; 68(2):279-287. PubMed ID: 32275078
[TBL] [Abstract][Full Text] [Related]
16. A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis.
Abuhusain HJ; Matin A; Qiao Q; Shen H; Kain N; Day BW; Stringer BW; Daniels B; Laaksonen MA; Teo C; McDonald KL; Don AS
J Biol Chem; 2013 Dec; 288(52):37355-64. PubMed ID: 24265321
[TBL] [Abstract][Full Text] [Related]
17. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.
Frati A; Ricci B; Pierucci F; Nistri S; Bani D; Meacci E
Mol Endocrinol; 2015 Jan; 29(1):53-67. PubMed ID: 25415609
[TBL] [Abstract][Full Text] [Related]
18. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
Ueda N
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
[TBL] [Abstract][Full Text] [Related]
19. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors.
Bassi R; Anelli V; Giussani P; Tettamanti G; Viani P; Riboni L
Glia; 2006 Apr; 53(6):621-30. PubMed ID: 16470810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
